Subclinical atherosclerosis evolution during 5 years of anti-TNF-alpha treatment in psoriatic arthritis patients

Ortolan, A; Ramonda, R; Lorenzin, M; Pesavento, R; Spinazze, A; Felicetti, M; Nardin, C; Rattazzi, M; Doria, A; Puato, M

Ramonda, R (corresponding author), Univ Padua, Divs Reumatol, Dipartimento Med DIMED, Via Giustiniani 2, I-35128 Padua, Italy.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021; 39 (1): 158

Abstract

Objectives. Our aim was to evaluate subclinical atherosclerosis progression during 5 years of anti-tumour necrosis factor (TNF)-alpha treatment in pso......

Full Text Link